1h Free Analyst Time
The global blood culture tests market is expected to grow at a CAGR of 7.81% from 2023 to 2029. Speak directly to the analyst to clarify any post sales queries you may have.
MARKET OPPORTUNITIES & TRENDS
Rising Development with Automated Blood Culture Test Systems
The automated blood culture test systems are a ray of hope in the blood culture tests market to increase the speed of diagnosis and reduce contamination rate. With the rising demand for rapid diagnosis of blood-associated and other infectious diseases, the requirement for advanced blood culture test systems is rapidly increasing across the market. These advanced systems are intended to make blood culture processing more efficient and streamlined, as stated by the National Library of Medicine Report 2021. Also, these systems reduce the demand for terminal or blind subculture bottles and increase the speed of test procedures. These systems are effective and efficient and increase blood culture test specificity and sensitivity; these factors are expected to deliver new market growth opportunities.Advances in Blood Culture Testing
The development and innovation of new technologies for blood culture testing are accelerating the blood culture tests market growth. Bloodstream diseases are a significant cause of severe health outcomes and death with growing incidence and severity. A general blood culture test is the standard method; however, the upcoming new technologies and advances, such as molecular-based diagnostics, are used as add-on complementary assays. It increases test speed and speed-up microbial detection and guesses antimicrobial susceptibility. Furthermore, innovations for blood culture testing, such as molecular testing technologies, are more accurate and sensitive than traditional methods. In the past few years, diagnosing bloodstream infections has relied on time-consuming basic blood cultures and traditional organism identification and susceptibility testing. Technologies to define the culprit in bloodstream infections have gained sophistication in recent years, notably by applying molecular diagnostic methods.Growing Demand for Early & Preventive Diagnosis
Globally, the rising concern about health drives the demand for early disease diagnosis, positively influencing the blood culture tests market growth. The accurate and early diagnosis of diseases is essential to prevent wasting patients' valuable time on the wrong course of treatments. When a patient gets an accurate diagnosis, it offers the best opportunities for positive health outcomes with the help of clinical decisions tailored to a correct understanding of the patient’s health issues. Bloodstream infections, specifically sepsis, are highly demanded for early and preventive diagnosis. Several government initiatives and healthcare policies favor early sepsis and other bloodstream infections. Also, the growing importance of accurate diagnosis is the leading factor accelerating the preference for blood culture tests in infectious disease management. Medical errors are one of the leading causes of death worldwide and were one of the leading causes of death in the U.S. in the past few years. The growing importance of accurate diagnosis of infectious diseases is accelerating visits to clinical laboratories and boosting the demand for blood culture tests and associated equipment and consumables.SEGMENTATION INSIGHTS
INSIGHTS BY SAMPLE TYPE
The global blood culture tests market by sample type is segmented into bacterial and non-bacterial samples. During the forecast period, the bacterial sample type segment accounted for the highest market share and dominated the market. Bacterial pathogens are significantly prevalent in bloodstream infections compared to other pathogens. Bacterial pathogens severely impact human health and drive the demand for early and preventive diagnosis, where the bacterial sample is commonly used in blood culture testing and accelerates segmental growth.Segmentation by Sample Type
- Bacterial Sample
- Non-bacterial Sample
INSIGHTS BY METHOD
The global blood culture tests market by method is segmented into manual/conventional blood culture and automated blood culture. Manual/conventional blood culture methods are traditional and familiar to lab operators. These methods are used longer, giving them high popularity and acceptance. In 2023, the manual/conventional blood culture method segment accounted for the largest share of the market. Manual/conventional blood culture methods are commonly used due to the convenience and affordability of required solutions. Conversely, automated blood culture methods are becoming more popular in recent years. The automation in sample processing gives high efficacy, resulting in the best delivery result. Also, automated blood culture systems are becoming more popular and the primary choice to identify pathogens from blood samples. Rather than manually reading broth-based conventional methods, labs now use continuously monitored automated systems to process blood culture samples.Segmentation by Method
- Manual/Conventional Blood Culture
- Automated Blood Culture
INSIGHTS BY PRODUCT
The consumables product segment holds the most significant share of the global blood culture tests market 2023. Consumables are in high demand due to their repetitive use in blood culture testing at all diagnostic laboratories and research centers. Also, some consumables can be used only once and must be discarded or replaced after some time. It increases the application rate and demand for consumables over test equipment. Further, the consumables include a range of solutions used in general to standard laboratories, which include reagents, filters, tubes, plates, and gloves. These consumables are commonly in demand in hospitals, life sciences, academic laboratories, etc.Segmentation by Product
- Consumables
- Test Equipment
INSIGHTS BY END-USERS
The global blood culture tests market by end-users is segmented into hospital-based laboratories, clinical laboratories, academic and research laboratories/centers, and others. The hospital-based laboratories segment accounted for over 45% of the highest market share in 2023. Blood culture tests are commonly performed in hospital-associated laboratory centers due to a significant patient population with infectious diseases and a higher prevalence of bloodstream infection in hospital settings. Hospital-acquired infections and associated risks commonly require blood culture tests and significantly contribute to segmental revenue growth.Segmentation by End-users
- Hospital-based Laboratories
- Clinical Laboratories
- Academic & Research Laboratories/Centers
- Others
GEOGRAPHICAL ANALYSIS
North America holds the largest share of the global blood culture tests market, accounting for a global revenue share of 35% in 2023. The region holds a significant market share due to the increasing burden of bloodstream infection across hospital settings, the rising burden of sepsis management, and the growing awareness and acceptance of automated blood culture systems. In addition, the presence of major market players in the U.S. accelerates the influencing demand and adoption of blood culture test equipment and consumables, fueling market growth.APAC is expected to witness the highest CAGR in the global blood culture tests market during the forecast period. The market growth in APAC is anticipated with the increasing burden of infectious diseases, such as bloodstream infection, sepsis, hospital-associated infection, and others. In addition, the rapid development in healthcare and life sciences is accelerating market growth. China and India are the two leading countries that have witnessed increasing development in the diagnostics field for preventive measures, and early diagnosis of infectious diseases is expected to drive significant market growth in these countries.
Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Russia
- Poland
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
VENDOR LANDSCAPE
Vendors can understand that the traditional blood culture test methods are the most used method over automated blood culture systems, where the automated systems are becoming a new ray of hope in the blood culture tests market. Vendors can develop advanced automated blood culture systems and achieve revenue growth opportunities. Furthermore, globally, bloodstream infection (BSI) and sepsis cases are most commonly reported in healthcare settings, where the demand for blood culture tests is continuously rising and is expected to deliver huge revenue growth opportunities.Very few automated blood culture test systems are available, and their acceptance is rising steadily in the market, which is a significant opportunity for vendors to develop new solutions. Also, there has been a slow shift from manual to automated blood culture test methods, where vendors can focus on increasing their market penetration by launching new automated systems.
Key Company Profiles
- BD
- BIOMÉRIEUX
- Bruker
- Danaher
- Terumo Corporation
- Thermo Fisher Scientific
Other Prominent Vendors
- Abbott
- Autobio
- Axiom
- Biolab Scientific
- Cardinal Health
- DiaSorin S.p.A.
- F. Hoffmann-La Roche
- Hardy Diagnostics
- HiMedia Laboratories
- ITL BioMedical
- Kurin Inc
- Labotronics Scientific
- Meditech Technologies India Private Limited
- OpGen
- Render Biotech Co., Ltd.
- SARSTEDT AG & Co KG
- Siemens Healthineers AG
- Scenker Biological Technology Co., Ltd
- T2 Biosystems (T2Bio)
KEY QUESTIONS ANSWERED
1. How big is the blood culture tests market?2. Which region dominates the global blood culture tests market share?
3. What are the significant trends in the blood culture tests market?
4. What is the growth rate of the global blood culture tests market?
5. Who are the global blood culture test market's key players?
Table of Contents
1 Scope & Coverage
2 Premium Insights
4 Introduction
5 Market Opportunities & Trends
6 Market Growth Enablers
7 Market Restraints
8 Market Landscape
9 Sample Type
10 Method
11 Product
12 End-user
13 Geography
14 North America
15 Europe
16 APAC
17 Latin America
18 Middle East & Africa
19 Competitive Landscape
20 Key Company Profiles
21 Other Prominent Vendors
22 Report Summary
23 Quantitative Summary
24 Appendix
List of Exhibits
List of Tables
Companies Mentioned
- BD
- BIOMÉRIEUX
- Bruker
- Danaher
- Terumo Corporation
- Thermo Fisher Scientific
- Abbott
- Autobio
- Axiom
- Biolab Scientific
- Cardinal Health
- DiaSorin S.p.A.
- F. Hoffmann-La Roche
- Hardy Diagnostics
- HiMedia Laboratories
- ITL BioMedical
- Kurin Inc
- Labotronics Scientific
- Meditech Technologies India Private Limited
- OpGen
- Render Biotech Co., Ltd.
- SARSTEDT AG & Co KG
- Siemens Healthineers AG
- Scenker Biological Technology Co., Ltd
- T2 Biosystems (T2Bio)
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 318 |
| Published | May 2024 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value ( USD | $ 5.72 Billion |
| Forecasted Market Value ( USD | $ 8.98 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
